Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
JCO Global Oncology|June 6, 2024
Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics StudyHikmat Abdel-Razeq, Baha' Sharaf, Hira Bani Hani, et al.
Journal of the American Academy of Dermatology|March 21, 2024
Germline cancer susceptibility in individuals with melanomaPauline Funchain, Ying Ni, Brandie Heald, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Mixed-effects polygenic risk score Phenome-wide association study detects genetic correlation between colorectal cancer risk and phenotype data extracted from the electronic health recordElisabeth A Rosenthal, Wei-Qi Wei, Yuan Luo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective StudyPedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.
Cureus|May 14, 2023
Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology ProgramJeremy C Jones, Michael A Golafshar, Tucker W Coston, et al.
American Journal of Human Genetics|September 2, 2022
Addressing underrepresentation in genomics research through community engagementAmy A Lemke, Edward D Esplin, Aaron J Goldenberg, et al.
NPJ Genomic Medicine|December 22, 2017
Germline hemizygous deletion of CDKN2A-CDKN2B locus in a patient presenting with Li-Fraumeni syndromeSock Hoai Chan, Weng Khong Lim, Scott T Michalski, et al.
Cell Reports|March 31, 2021
Trans-ethnic variation in germline variants of patients with renal cell carcinomaSarah Abou Alaiwi, Amin H Nassar, Elio Adib, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinomaAmin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Prostate Cancer and Prostatic Diseases|September 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patientsNeal D Shore, Christopher M Pieczonka, Sean Heron, et al.
Pageof 10